◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

CRISIL Limited (CRISIL) Revenue 2022–TTM

Name: CRISIL Limited (CRISIL) revenue history 2022-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-11-01

CRISIL Limited annual revenue for fiscal TTM was ₹43.1 billion, an increase of 18.1% from ₹36.5 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

CRISIL Annual Revenue

Revenue (annual)	TTM → 2026-09-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Total Revenue	₹43.1B	₹36.5B	₹32.6B	₹31.4B	₹27.7B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CRISIL Quarterly Revenue

Revenue (quarterly)	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹11.0B	₹10.8B	₹10.6B	₹10.8B	—	₹8.4B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Revenue at Comparable Companies

8697 Revenue — Japan Exchange Group, Inc.
BSE Revenue — BSE Limited
MCX Revenue — Multi Commodity Exchange of India Limited
0388 Revenue — Hong Kong Exchanges and Clearing Limited

More CRISIL metrics: Gross Profit · Operating Income · Net Income · EPS · Free Cash Flow

All CRISIL financial statements → Interactive CRISIL charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.